Microplastics/U.S. Government Accountability Office: Congressional Request to Review U.S. EPA Efforts to Assess Presence/Risk
24 Members of Congress and United States Senators have written the U.S. Government Accountability Office (“GAO”) in a September 28th letter asking that it: … conduct a comprehensive review of the Environmental Protection Agency's (“EPA”) efforts to effectively assess the presence and risks…
Oil Discharge Enforcement: Virginia Department of Environmental Quality and Manassas Biological Resource Center Enter into Order by Consent
The Virginia Department of Environmental Quality (“VDEQ”) and America Type Culture Collection (“ATCC”) entered into a August 31st Order by Consent (“Order”) addressing an alleged discharge of oil. The Order provides that ATCC owns and operates a private, nonprofit, global biological resource center…
Waters of the United States/Clean Water Act: Trout Unlimited Comments on U.S. EPA Supplemental Proposed Rule
Trout Unlimited (“TU”) submitted October 9th comments addressing the United States Environmental Protection Agency’s: Supplemental Notice of Proposed Rulemaking, Updated Definition of “Waters of the United States” (“Supplemental Proposed Rule”). See Docket No. EPA-HQ-OW-2025-0322; 91 Fed. Reg…
Emerging Environmental Issues: Arkansas Environmental Federation Convention - October 8th Presentation
I undertook a presentation at the Arkansas Environmental Federation Convention titled: Emerging Environmental Issues (“Presentation”). The focus of the Presentation addressed various statutory and environmental media emerging issues. The Presentation addressed the following: Definition of…
Pretreatment Enforcement/Clean Water Act: Mississippi Commission on Environmental Quality and Gulf Port Pharmaceutical Manufacturing Facility Enter into Agreed Order
The Mississippi Commission on Environmental Quality (“MCEQ”) and GCP Laboratories, Inc. (“GCP”) entered into an August 18th Agreed Order (“AO”) addressing alleged violations of a Clean Water Act Pretreatment Permit. See Order No. 7742 26. The AO provides that GCP operates a pharmaceutical…